Skip to main content
. 1998 Mar 3;95(5):2441–2445. doi: 10.1073/pnas.95.5.2441

Figure 1.

Figure 1

Th1 immune responsiveness from mice treated with OVA at birth after immunization with OVA (50 μg)/CFA. Serum OVA-specific IgG2a levels from OVA-treated mice were reduced to 35% of serum levels from PBS treated control mice (P < 0.05, n = 5). IFN-γ levels produced by spleen cells from mice treated with OVA were reduced to 18% of the level produced by spleen cells from PBS-treated controls (P < 0.05, n = 5). Proliferation of splenocytes from OVA-treated mice was reduced to 31% in comparison to PBS treated controls (P < 0.05, n = 3).